Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma

Condition:   Asthma
Interventions:   Drug: Indacaterol acetate 75 ?g;   Drug: Indacaterol acetate 150 ?g
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting – verified August 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.